{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T11:17:46Z","timestamp":1785842266197,"version":"3.56.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,3]],"date-time":"2019-12-03T00:00:00Z","timestamp":1575331200000},"content-version":"vor","delay-in-days":3957,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Inger and John Fredriksens's Foundation for Ovarian Cancer Research"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1093\/annonc\/mdn591","type":"journal-article","created":{"date-parts":[[2008,8,25]],"date-time":"2008-08-25T20:34:10Z","timestamp":1219696450000},"page":"286-293","source":"Crossref","is-referenced-by-count":57,"title":["The role of secondary cytoreduction in the management of the first relapse in epithelial ovarian cancer"],"prefix":"10.1016","volume":"20","author":[{"given":"H.","family":"Oksefjell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Sandstad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Trop\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mdn591_bb0010","author":"Cancer in Norway","year":"2006"},{"key":"10.1093\/annonc\/mdn591_bb0015","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1006\/gyno.1998.4955","article-title":"Complete cytoreductive surgery is feasible and maximizes survival in patients with advanced epithelial ovarian cancer: a prospective study","volume":"69","author":"Eisenkop","year":"1998","journal-title":"Gynecol Oncol"},{"key":"10.1093\/annonc\/mdn591_bb0020","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1016\/S0140-6736(03)13718-X","article-title":"Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer; the ICON4\/AGO-OVAR-2.2 trial","volume":"361","author":"The ICON and AGO Collaborators","year":"2003","journal-title":"Lancet"},{"issue":"Suppl 1","key":"10.1093\/annonc\/mdn591_bb0025","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1136\/ijgc-00009577-200505001-00007","article-title":"Combination therapy with gemcitabine and carboplatin in recurrent ovarian cancer","volume":"15","author":"AGO-OVAR NCIC CTG & EORTC GCG","year":"2005","journal-title":"Int J Gynecol Cancer"},{"key":"10.1093\/annonc\/mdn591_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ygyno.2004.07.011","article-title":"on behalf of the Doxil Study 30-49 Investigators. Long-term survival advantage for women treated with pegylated liposomal doxorubicin compared with topotecan in a phase 3 randomized study of recurrent and refractory epithelial ovarian cancer","volume":"95","author":"Gordon","year":"2004","journal-title":"Gynecol Oncol"},{"key":"10.1093\/annonc\/mdn591_bb0035","series-title":"Principles and Practice of Gynecologic Oncology","first-page":"895","article-title":"Epithelial ovarian cancer","author":"Ozols","year":"2005"},{"key":"10.1093\/annonc\/mdn591_bb0040","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.ygyno.2007.05.008","article-title":"Duration of second or greater complete clinical remission in ovarian cancer: exploring potential endpoints for clinical trials","volume":"106","author":"Harrison","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1093\/annonc\/mdn591_bb0045","first-page":"189","article-title":"Survival of patients following secondary cytoreductive surgery in ovarian cancer","volume":"61","author":"Berek","year":"1983","journal-title":"Obset Gynecol"},{"key":"10.1093\/annonc\/mdn591_bb0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0090-8258(89)90593-3","article-title":"Secondary cytoreductive surgery in epithelial ovarian cancer. Nonresponders to first-line therapy","volume":"33","author":"Morris","year":"1989","journal-title":"Gynecol Oncol"},{"key":"10.1093\/annonc\/mdn591_bb0055","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1006\/gyno.2001.6143","article-title":"Secondary cytoreductive surgery for localized intra-abdominal recurrences in epithelial ovarian cancer","volume":"81","author":"Munkarah","year":"2001","journal-title":"Gynecol Oncol"},{"key":"10.1093\/annonc\/mdn591_bb0060","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/1096-9098(200009)75:1<24::AID-JSO5>3.0.CO;2-L","article-title":"Effect of cytoreductive surgery on survival of patients with recurrent epithelial ovarian cancer","volume":"75","author":"Zang","year":"2000","journal-title":"J Surg Oncol"},{"key":"10.1093\/annonc\/mdn591_bb0065","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/cncr.10789","article-title":"Recurrent micropapillary serous ovarian carcinoma","volume":"95","author":"Bristow","year":"2002","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdn591_bb0070","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1002\/cncr.20106","article-title":"Secondary cytoreductive surgery for patients with relapsed epithelial ovarian carcinoma: who benefits?","volume":"100","author":"Zang","year":"2004","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdn591_bb0075","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1002\/cncr.21845","article-title":"Guidelines and selection criteria for secondary cytoreductive surgery in patients with recurrent, platinum-sensitive epithelial ovarian carcinoma","volume":"106","author":"Chi","year":"2006","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdn591_bb0080","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/j.1447-0756.2006.00460.x","article-title":"Role of salvage cytoreductive surgery in the treatment of patients with recurrent ovarian cancer after platinum-based chemotherapy","volume":"32","author":"Matsumoto","year":"2006","journal-title":"J Obstet Gynaecol Res"},{"key":"10.1093\/annonc\/mdn591_bb0085","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1245\/s10434-006-9273-8","article-title":"Secondary cytoreductive surgery in patients with platinum-sensitive recurrent ovarian cancer","volume":"14","author":"Benedetti Panici","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"10.1093\/annonc\/mdn591_bb0090","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.ygyno.2006.10.020","article-title":"Secondary cytoreductive surgery for isolated nodal recurrence in patients with epithelial ovarian cancer","volume":"104","author":"Santillan","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1093\/annonc\/mdn591_bb0095","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/cncr.22447","article-title":"Secondary cytoreductive surgery for localized, recurrent epithelial ovarian cancer: analysis of prognostic factors and survival outcome","volume":"109","author":"Salani","year":"2007","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdn591_bb0100","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1245\/s10434-006-9058-0","article-title":"Surgery in recurrent ovarian cancer: the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) DESKTOP OVAR Trial","volume":"13","author":"Harter","year":"2006","journal-title":"Ann Surg Oncol"},{"issue":"Suppl 3","key":"10.1093\/annonc\/mdn591_bb0105","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1525-1438.2005.00430.x","article-title":"The role of surgery in recurrent ovarian cancer","volume":"15","author":"Pfisterer","year":"2005","journal-title":"Int J Gynecol Cancer"},{"key":"10.1093\/annonc\/mdn591_bb0110","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.ygyno.2007.04.006","article-title":"Cytoreductive surgery for patients with recurrent epithelial ovarian carcinoma","volume":"106","author":"Tebes","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1093\/annonc\/mdn591_bb0115","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1006\/gyno.2000.5992","article-title":"Complete salvage surgical cytoreduction improves further survival of patients with late recurrent ovarian cancer","volume":"79","author":"Gadducci","year":"2000","journal-title":"Gynecol Oncol"},{"issue":"Suppl 1","key":"10.1093\/annonc\/mdn591_bb0120","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0923-7534(20)31477-0","article-title":"Surgery during chemotherapy and at relapse of ovarian cancer","volume":"10","author":"Berek","year":"1999","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdn591_bb0125","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ajog.2005.06.048","article-title":"The role of secondary cytoreduction in the treatment of ovarian cancer: Hacettepe University experience","volume":"194","author":"Ayhan","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"10.1093\/annonc\/mdn591_bb0130","series-title":"Surgery for the resolution of symptoms in malignant bowel obstruction in advanced gynaecological and gastrointestinal cancer. CD002764","author":"Feuer","year":"2000"},{"issue":"Suppl 4","key":"10.1093\/annonc\/mdn591_bb0135","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1002\/cncr.2820710422","article-title":"Second-line chemotherapy for recurrent carcinoma of the ovary","volume":"71","author":"Thigpen","year":"1993","journal-title":"Cancer"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092375341940478X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092375341940478X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/20\/2\/286\/392083\/mdn591.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,20]],"date-time":"2020-02-20T07:29:37Z","timestamp":1582183777000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092375341940478X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["S092375341940478X"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdn591","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1124043.581159","asserted-by":"object"}]},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2009,2]]}}}